Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide for Patients With Hematologic Malignancies

NCT02793544 is registered in ClinicalTrials.gov with Center for International Blood and Marrow Transplant Research as lead sponsor.

NCT NCT02793544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02793544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide for Patients With Hematologic Malignancies
Lead sponsor
Center for International Blood and Marrow Transplant Research
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2016
Completion date
March 31, 2020
Enrollment
80 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

acute biphenotypic leukemia (abl), acute lymphoblastic leukemia (all)/t lymphoblastic lymphoma, acute myelogenous leukemia (aml), acute undifferentiated leukemia (aul), chemotherapy-sensitive lymphoma, chronic lymphocytic leukemia (cll), myelodysplastic syndrome (mds)